Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v17-EN Version v8-FR
Language English French
Date Updated 2018-12-21 2018-06-13
Drug Identification Number 02231056 02231056
Brand name HAVRIX 720 JUNIOR HAVRIX 720 JUNIOR
Common or Proper name hepatitis A vaccine, inactivated hepatitis A vaccine, inactivated
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients HEPATITIS A VACCINE, INACTIVATED HEPATITIS A VACCINE, INACTIVATED
Strength(s) 720UNIT 720UNIT
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1's (prefilled syringe / seringue préremplie) 1's (prefilled syringe / seringue préremplie)
ATC code J07BC J07BC
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2018-04-04 2018-04-04
Estimated end date 2019-01-04 2018-12-31
Actual end date 2018-12-20
Shortage status Resolved Actual shortage
Company comments Most recent supply released May 30, 2018 with limited quantity. Supply disruptions may be seen in the private market. Product under allocation.
Health Canada comments